Review



vx745  (Tocris)


Bioz Verified Symbol Tocris is a verified supplier
Bioz Manufacturer Symbol Tocris manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Tocris vx745
    Selectivity of SB203580, BIRB796, and <t> VX745 </t> for p38α/β/δ/γ
    Vx745, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 22 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vx745/product/Tocris
    Average 93 stars, based on 22 article reviews
    vx745 - by Bioz Stars, 2026-06
    93/100 stars

    Images

    1) Product Images from "Interplay between nuclear factor-κB, p38 MAPK, and glucocorticoid receptor signaling synergistically induces functional TLR2 in lung epithelial cells"

    Article Title: Interplay between nuclear factor-κB, p38 MAPK, and glucocorticoid receptor signaling synergistically induces functional TLR2 in lung epithelial cells

    Journal: The Journal of Biological Chemistry

    doi: 10.1016/j.jbc.2022.101747

    Selectivity of SB203580, BIRB796, and  VX745  for p38α/β/δ/γ
    Figure Legend Snippet: Selectivity of SB203580, BIRB796, and VX745 for p38α/β/δ/γ

    Techniques Used:

    p38α MAPK inhibition upregulates IL1B-induced TLR2 expression and R1+R2-reporter activity. A , A549 cells were either not treated or pretreated with BIRB796 at various concentrations for 30 min prior to stimulation with IL1B (1 ng/ml). The cells were harvested at 30 min for Western blot analysis and 6 h for qPCR analysis. Blots representative of N independent experiments for phospho-MK2 (P-MK2), total MK2 (MK2), and GAPDH are shown. Densitometric data for P-MK2 and TLR2 mRNA, each normalized to GAPDH, were plotted as fold relative to untreated. B , pHBECs grown in submersion culture were either not stimulated or pretreated with BIRB796 (100 nM) or VX745 (300 nM) for 30 min, followed by addition of IL1B. The cells were harvested for qPCR analysis at 2 and 6 h. U pper panel , TLR2 mRNA was normalized to GAPDH and ( lower panel ) TLR2 unRNA was normalized to U6. In each case, data from N independent experiments were expressed as fold relative to untreated control. C , A549 cells were incubated with concentrations of p38α siRNAs ( si5 , si7 , and si12 ) as indicated, prior to addition of IL1B. The cells were harvested after 30 min and 8 h for western blot analysis. Blots representative of at least four independent experiments are shown. D , A549 cells were incubated with either control siRNA ( siC ), p38α siRNAs ( si5 , si7 , and si12 ), or p38β siRNAs ( si4 , si6 , and si7 ), each at 1 nM, followed by treatment with IL1B. The cells were harvested at 6 h for qPCR analysis. TLR2 mRNA data from N independent experiments was normalized to GAPDH and expressed as fold of untreated. A549 cells stably harboring the R1+R2-luc reporter were either ( E ) incubated with pools of the p38α or p38β siRNAs used in C and D (1 nM) or ( F ) pretreated with BIRB796 (100 nM) or VX745 (300 nM) for 30 min, followed by treatment with IL1B. The cells were harvested for luciferase assay at indicated times. Luciferase activity from N independent experiments was expressed as fold relative to untreated. In B , D , E , and F , significance relative to IL1B was tested by ANOVA with a Dunnett’s post-hoc test. In F , ∗ and $ represent significance of IL1B+BIRB796 and IL1B+VX745, respectively, relative to IL1B. G , A549 cells were either not treated or pretreated with BIRB796 (100 nM) for 30 min, followed by addition of IL1B and/or dexamethasone ( Dex ; 1 μM). The cells were harvested at the indicated times, and ChIP-qPCR for p65 was performed. Data from N independent experiments were plotted as log 2 fold enrichment. ∗ p ≤ 0.05, ∗∗ p ≤ 0.01, ∗∗∗ p ≤ 0.001. ChIP, chromatin immunoprecipitation MAPK, mitogen-activated protein kinase; pHBEC, primary human bronchial epithelial cell; qPCR, quantitative PCR; TLR, toll-like receptor.
    Figure Legend Snippet: p38α MAPK inhibition upregulates IL1B-induced TLR2 expression and R1+R2-reporter activity. A , A549 cells were either not treated or pretreated with BIRB796 at various concentrations for 30 min prior to stimulation with IL1B (1 ng/ml). The cells were harvested at 30 min for Western blot analysis and 6 h for qPCR analysis. Blots representative of N independent experiments for phospho-MK2 (P-MK2), total MK2 (MK2), and GAPDH are shown. Densitometric data for P-MK2 and TLR2 mRNA, each normalized to GAPDH, were plotted as fold relative to untreated. B , pHBECs grown in submersion culture were either not stimulated or pretreated with BIRB796 (100 nM) or VX745 (300 nM) for 30 min, followed by addition of IL1B. The cells were harvested for qPCR analysis at 2 and 6 h. U pper panel , TLR2 mRNA was normalized to GAPDH and ( lower panel ) TLR2 unRNA was normalized to U6. In each case, data from N independent experiments were expressed as fold relative to untreated control. C , A549 cells were incubated with concentrations of p38α siRNAs ( si5 , si7 , and si12 ) as indicated, prior to addition of IL1B. The cells were harvested after 30 min and 8 h for western blot analysis. Blots representative of at least four independent experiments are shown. D , A549 cells were incubated with either control siRNA ( siC ), p38α siRNAs ( si5 , si7 , and si12 ), or p38β siRNAs ( si4 , si6 , and si7 ), each at 1 nM, followed by treatment with IL1B. The cells were harvested at 6 h for qPCR analysis. TLR2 mRNA data from N independent experiments was normalized to GAPDH and expressed as fold of untreated. A549 cells stably harboring the R1+R2-luc reporter were either ( E ) incubated with pools of the p38α or p38β siRNAs used in C and D (1 nM) or ( F ) pretreated with BIRB796 (100 nM) or VX745 (300 nM) for 30 min, followed by treatment with IL1B. The cells were harvested for luciferase assay at indicated times. Luciferase activity from N independent experiments was expressed as fold relative to untreated. In B , D , E , and F , significance relative to IL1B was tested by ANOVA with a Dunnett’s post-hoc test. In F , ∗ and $ represent significance of IL1B+BIRB796 and IL1B+VX745, respectively, relative to IL1B. G , A549 cells were either not treated or pretreated with BIRB796 (100 nM) for 30 min, followed by addition of IL1B and/or dexamethasone ( Dex ; 1 μM). The cells were harvested at the indicated times, and ChIP-qPCR for p65 was performed. Data from N independent experiments were plotted as log 2 fold enrichment. ∗ p ≤ 0.05, ∗∗ p ≤ 0.01, ∗∗∗ p ≤ 0.001. ChIP, chromatin immunoprecipitation MAPK, mitogen-activated protein kinase; pHBEC, primary human bronchial epithelial cell; qPCR, quantitative PCR; TLR, toll-like receptor.

    Techniques Used: Inhibition, Expressing, Activity Assay, Western Blot, Control, Incubation, Stable Transfection, Luciferase, ChIP-qPCR, Chromatin Immunoprecipitation, Real-time Polymerase Chain Reaction

    Fold differences between IL1B+MAPK inhibitor and IL1B-plus-dexamethasone-induced TLR2 mRNA and unRNA
    Figure Legend Snippet: Fold differences between IL1B+MAPK inhibitor and IL1B-plus-dexamethasone-induced TLR2 mRNA and unRNA

    Techniques Used:



    Similar Products

    93
    Bio-Techne corporation vx 745
    Vx 745, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vx 745/product/Bio-Techne corporation
    Average 93 stars, based on 1 article reviews
    vx 745 - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    90
    Cayman Chemical vx745
    Vx745, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vx745/product/Cayman Chemical
    Average 90 stars, based on 1 article reviews
    vx745 - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    91
    Santa Cruz Biotechnology vx745
    Vx745, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vx745/product/Santa Cruz Biotechnology
    Average 91 stars, based on 1 article reviews
    vx745 - by Bioz Stars, 2026-06
    91/100 stars
      Buy from Supplier

    93
    Tocris vx745
    Selectivity of SB203580, BIRB796, and <t> VX745 </t> for p38α/β/δ/γ
    Vx745, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vx745/product/Tocris
    Average 93 stars, based on 1 article reviews
    vx745 - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    93
    Selleck Chemicals vx745
    Western blot analysis of kCer-induced HaCaT cell differentiation and signaling pathway activation. ( A ) Effects of treatments (0, 1, and 10 μM kCer) on cell protein (c-Fos, p-c-Fos, p38, and p-p38) expression were measured by Western blot analysis. The blotted bands were analyzed by Image J and graphed as shown below. Bars represent the relative ratios of p-c-Fos/c-Fos, p-p38/p38, and involucrin/β-Actin. ( B ) Effects of treatment with 10 μM kCer treatment ±1.0 μM of the p38MAPK inhibitor SB203580 (p38α/p38β), BIRB796 (p38α/p38β/p38γ/p38δ), or <t>VX745</t> (p38α/p38β/p38δ), respectively. Cell lysates were subjected to immunoblot analysis, followed by detection of p-c-Fos, c-Fos, p-p38, p38, and β-Actin. Immunoblot bands were analyzed by Image J, and the relative ratios of p-p38/p38 and p-c-Fos/c-Fos are graphed below. Data are presented as means ± SD ( n = 3, ** p < 0.01, * p < 0.05).
    Vx745, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vx745/product/Selleck Chemicals
    Average 93 stars, based on 1 article reviews
    vx745 - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    91
    Santa Cruz Biotechnology p38 vx745 inhibitors
    Western blot analysis of kCer-induced HaCaT cell differentiation and signaling pathway activation. ( A ) Effects of treatments (0, 1, and 10 μM kCer) on cell protein (c-Fos, p-c-Fos, p38, and p-p38) expression were measured by Western blot analysis. The blotted bands were analyzed by Image J and graphed as shown below. Bars represent the relative ratios of p-c-Fos/c-Fos, p-p38/p38, and involucrin/β-Actin. ( B ) Effects of treatment with 10 μM kCer treatment ±1.0 μM of the p38MAPK inhibitor SB203580 (p38α/p38β), BIRB796 (p38α/p38β/p38γ/p38δ), or <t>VX745</t> (p38α/p38β/p38δ), respectively. Cell lysates were subjected to immunoblot analysis, followed by detection of p-c-Fos, c-Fos, p-p38, p38, and β-Actin. Immunoblot bands were analyzed by Image J, and the relative ratios of p-p38/p38 and p-c-Fos/c-Fos are graphed below. Data are presented as means ± SD ( n = 3, ** p < 0.01, * p < 0.05).
    P38 Vx745 Inhibitors, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/p38 vx745 inhibitors/product/Santa Cruz Biotechnology
    Average 91 stars, based on 1 article reviews
    p38 vx745 inhibitors - by Bioz Stars, 2026-06
    91/100 stars
      Buy from Supplier

    Image Search Results


    Selectivity of SB203580, BIRB796, and  VX745  for p38α/β/δ/γ

    Journal: The Journal of Biological Chemistry

    Article Title: Interplay between nuclear factor-κB, p38 MAPK, and glucocorticoid receptor signaling synergistically induces functional TLR2 in lung epithelial cells

    doi: 10.1016/j.jbc.2022.101747

    Figure Lengend Snippet: Selectivity of SB203580, BIRB796, and VX745 for p38α/β/δ/γ

    Article Snippet: Budesonide (gift from AstraZeneca), dexamethasone (Sigma-Aldrich), SB203580 (Calbiochem), JNK-IN-VIII (Calbiochem), U0126 (Calbiochem), BIRB796 (Tocris), and VX745 (Tocris) were dissolved in dimethyl sulfoxide as stocks of 10 μM.

    Techniques:

    p38α MAPK inhibition upregulates IL1B-induced TLR2 expression and R1+R2-reporter activity. A , A549 cells were either not treated or pretreated with BIRB796 at various concentrations for 30 min prior to stimulation with IL1B (1 ng/ml). The cells were harvested at 30 min for Western blot analysis and 6 h for qPCR analysis. Blots representative of N independent experiments for phospho-MK2 (P-MK2), total MK2 (MK2), and GAPDH are shown. Densitometric data for P-MK2 and TLR2 mRNA, each normalized to GAPDH, were plotted as fold relative to untreated. B , pHBECs grown in submersion culture were either not stimulated or pretreated with BIRB796 (100 nM) or VX745 (300 nM) for 30 min, followed by addition of IL1B. The cells were harvested for qPCR analysis at 2 and 6 h. U pper panel , TLR2 mRNA was normalized to GAPDH and ( lower panel ) TLR2 unRNA was normalized to U6. In each case, data from N independent experiments were expressed as fold relative to untreated control. C , A549 cells were incubated with concentrations of p38α siRNAs ( si5 , si7 , and si12 ) as indicated, prior to addition of IL1B. The cells were harvested after 30 min and 8 h for western blot analysis. Blots representative of at least four independent experiments are shown. D , A549 cells were incubated with either control siRNA ( siC ), p38α siRNAs ( si5 , si7 , and si12 ), or p38β siRNAs ( si4 , si6 , and si7 ), each at 1 nM, followed by treatment with IL1B. The cells were harvested at 6 h for qPCR analysis. TLR2 mRNA data from N independent experiments was normalized to GAPDH and expressed as fold of untreated. A549 cells stably harboring the R1+R2-luc reporter were either ( E ) incubated with pools of the p38α or p38β siRNAs used in C and D (1 nM) or ( F ) pretreated with BIRB796 (100 nM) or VX745 (300 nM) for 30 min, followed by treatment with IL1B. The cells were harvested for luciferase assay at indicated times. Luciferase activity from N independent experiments was expressed as fold relative to untreated. In B , D , E , and F , significance relative to IL1B was tested by ANOVA with a Dunnett’s post-hoc test. In F , ∗ and $ represent significance of IL1B+BIRB796 and IL1B+VX745, respectively, relative to IL1B. G , A549 cells were either not treated or pretreated with BIRB796 (100 nM) for 30 min, followed by addition of IL1B and/or dexamethasone ( Dex ; 1 μM). The cells were harvested at the indicated times, and ChIP-qPCR for p65 was performed. Data from N independent experiments were plotted as log 2 fold enrichment. ∗ p ≤ 0.05, ∗∗ p ≤ 0.01, ∗∗∗ p ≤ 0.001. ChIP, chromatin immunoprecipitation MAPK, mitogen-activated protein kinase; pHBEC, primary human bronchial epithelial cell; qPCR, quantitative PCR; TLR, toll-like receptor.

    Journal: The Journal of Biological Chemistry

    Article Title: Interplay between nuclear factor-κB, p38 MAPK, and glucocorticoid receptor signaling synergistically induces functional TLR2 in lung epithelial cells

    doi: 10.1016/j.jbc.2022.101747

    Figure Lengend Snippet: p38α MAPK inhibition upregulates IL1B-induced TLR2 expression and R1+R2-reporter activity. A , A549 cells were either not treated or pretreated with BIRB796 at various concentrations for 30 min prior to stimulation with IL1B (1 ng/ml). The cells were harvested at 30 min for Western blot analysis and 6 h for qPCR analysis. Blots representative of N independent experiments for phospho-MK2 (P-MK2), total MK2 (MK2), and GAPDH are shown. Densitometric data for P-MK2 and TLR2 mRNA, each normalized to GAPDH, were plotted as fold relative to untreated. B , pHBECs grown in submersion culture were either not stimulated or pretreated with BIRB796 (100 nM) or VX745 (300 nM) for 30 min, followed by addition of IL1B. The cells were harvested for qPCR analysis at 2 and 6 h. U pper panel , TLR2 mRNA was normalized to GAPDH and ( lower panel ) TLR2 unRNA was normalized to U6. In each case, data from N independent experiments were expressed as fold relative to untreated control. C , A549 cells were incubated with concentrations of p38α siRNAs ( si5 , si7 , and si12 ) as indicated, prior to addition of IL1B. The cells were harvested after 30 min and 8 h for western blot analysis. Blots representative of at least four independent experiments are shown. D , A549 cells were incubated with either control siRNA ( siC ), p38α siRNAs ( si5 , si7 , and si12 ), or p38β siRNAs ( si4 , si6 , and si7 ), each at 1 nM, followed by treatment with IL1B. The cells were harvested at 6 h for qPCR analysis. TLR2 mRNA data from N independent experiments was normalized to GAPDH and expressed as fold of untreated. A549 cells stably harboring the R1+R2-luc reporter were either ( E ) incubated with pools of the p38α or p38β siRNAs used in C and D (1 nM) or ( F ) pretreated with BIRB796 (100 nM) or VX745 (300 nM) for 30 min, followed by treatment with IL1B. The cells were harvested for luciferase assay at indicated times. Luciferase activity from N independent experiments was expressed as fold relative to untreated. In B , D , E , and F , significance relative to IL1B was tested by ANOVA with a Dunnett’s post-hoc test. In F , ∗ and $ represent significance of IL1B+BIRB796 and IL1B+VX745, respectively, relative to IL1B. G , A549 cells were either not treated or pretreated with BIRB796 (100 nM) for 30 min, followed by addition of IL1B and/or dexamethasone ( Dex ; 1 μM). The cells were harvested at the indicated times, and ChIP-qPCR for p65 was performed. Data from N independent experiments were plotted as log 2 fold enrichment. ∗ p ≤ 0.05, ∗∗ p ≤ 0.01, ∗∗∗ p ≤ 0.001. ChIP, chromatin immunoprecipitation MAPK, mitogen-activated protein kinase; pHBEC, primary human bronchial epithelial cell; qPCR, quantitative PCR; TLR, toll-like receptor.

    Article Snippet: Budesonide (gift from AstraZeneca), dexamethasone (Sigma-Aldrich), SB203580 (Calbiochem), JNK-IN-VIII (Calbiochem), U0126 (Calbiochem), BIRB796 (Tocris), and VX745 (Tocris) were dissolved in dimethyl sulfoxide as stocks of 10 μM.

    Techniques: Inhibition, Expressing, Activity Assay, Western Blot, Control, Incubation, Stable Transfection, Luciferase, ChIP-qPCR, Chromatin Immunoprecipitation, Real-time Polymerase Chain Reaction

    Fold differences between IL1B+MAPK inhibitor and IL1B-plus-dexamethasone-induced TLR2 mRNA and unRNA

    Journal: The Journal of Biological Chemistry

    Article Title: Interplay between nuclear factor-κB, p38 MAPK, and glucocorticoid receptor signaling synergistically induces functional TLR2 in lung epithelial cells

    doi: 10.1016/j.jbc.2022.101747

    Figure Lengend Snippet: Fold differences between IL1B+MAPK inhibitor and IL1B-plus-dexamethasone-induced TLR2 mRNA and unRNA

    Article Snippet: Budesonide (gift from AstraZeneca), dexamethasone (Sigma-Aldrich), SB203580 (Calbiochem), JNK-IN-VIII (Calbiochem), U0126 (Calbiochem), BIRB796 (Tocris), and VX745 (Tocris) were dissolved in dimethyl sulfoxide as stocks of 10 μM.

    Techniques:

    Western blot analysis of kCer-induced HaCaT cell differentiation and signaling pathway activation. ( A ) Effects of treatments (0, 1, and 10 μM kCer) on cell protein (c-Fos, p-c-Fos, p38, and p-p38) expression were measured by Western blot analysis. The blotted bands were analyzed by Image J and graphed as shown below. Bars represent the relative ratios of p-c-Fos/c-Fos, p-p38/p38, and involucrin/β-Actin. ( B ) Effects of treatment with 10 μM kCer treatment ±1.0 μM of the p38MAPK inhibitor SB203580 (p38α/p38β), BIRB796 (p38α/p38β/p38γ/p38δ), or VX745 (p38α/p38β/p38δ), respectively. Cell lysates were subjected to immunoblot analysis, followed by detection of p-c-Fos, c-Fos, p-p38, p38, and β-Actin. Immunoblot bands were analyzed by Image J, and the relative ratios of p-p38/p38 and p-c-Fos/c-Fos are graphed below. Data are presented as means ± SD ( n = 3, ** p < 0.01, * p < 0.05).

    Journal: Biology

    Article Title: Konjac Ceramide (kCer)-Mediated Signal Transduction of the Sema3A Pathway Promotes HaCaT Keratinocyte Differentiation

    doi: 10.3390/biology11010121

    Figure Lengend Snippet: Western blot analysis of kCer-induced HaCaT cell differentiation and signaling pathway activation. ( A ) Effects of treatments (0, 1, and 10 μM kCer) on cell protein (c-Fos, p-c-Fos, p38, and p-p38) expression were measured by Western blot analysis. The blotted bands were analyzed by Image J and graphed as shown below. Bars represent the relative ratios of p-c-Fos/c-Fos, p-p38/p38, and involucrin/β-Actin. ( B ) Effects of treatment with 10 μM kCer treatment ±1.0 μM of the p38MAPK inhibitor SB203580 (p38α/p38β), BIRB796 (p38α/p38β/p38γ/p38δ), or VX745 (p38α/p38β/p38δ), respectively. Cell lysates were subjected to immunoblot analysis, followed by detection of p-c-Fos, c-Fos, p-p38, p38, and β-Actin. Immunoblot bands were analyzed by Image J, and the relative ratios of p-p38/p38 and p-c-Fos/c-Fos are graphed below. Data are presented as means ± SD ( n = 3, ** p < 0.01, * p < 0.05).

    Article Snippet: The following chemicals were used for relevant inhibitor analysis: Rho pathway inhibitor I Rho kinase (ROCK) inhibitor Y-27632 (Cytoskeleton, Inc., CN069, Denver, CO, USA), Rac-1 inhibitor NSC237669 (AXN, Axon1578, Scottsdale, AZ, USA), p38 MAPK inhibitors SB203580 (AdipoGen, AG-CR1-0030, San Diego, CA, USA), BIRB796 (Selleck, S1574, Pittsburgh, PA, USA), and VX745 (Selleck, S1458).

    Techniques: Western Blot, Cell Differentiation, Activation Assay, Expressing